10-QPeriod: Q2 FY2002

STRYKER CORP Quarterly Report for Q2 Ended Jun 30, 2002

Filed August 12, 2002For Securities:SYK

Summary

Stryker Corporation (SYK) reported solid financial performance for the six months and second quarter ended June 30, 2002. Net sales saw a significant increase of 13% for the first six months and 15% for the second quarter compared to the prior year, driven by strong performance in both the Orthopaedic Implants and MedSurg Equipment segments. Net earnings also showed robust growth, increasing by 29% for the six-month period and 31% for the second quarter, reflecting improved operational efficiency and the benefits of adopting new accounting standards for goodwill. The company is actively managing its business through strategic acquisitions and operational restructuring. Notably, the acquisition of Surgical Dynamics' spinal implant business closed on July 1, 2002, expected to be neutral to earnings in 2002 and accretive thereafter. Additionally, Stryker is planning to close its Rutherford, New Jersey manufacturing facility over the next 18 months, a move anticipated to increase gross margins and reduce inventory, with a tentative agreement reached with the union.

Key Highlights

  • 1Net sales increased by 13% year-over-year for the first six months of 2002 to $1.44 billion, and by 15% in the second quarter to $733.9 million.
  • 2Net earnings grew significantly, up 29% for the six-month period to $167.0 million and 31% for the second quarter to $85.9 million.
  • 3Adoption of FASB Statement No. 142 reduced amortization expense and boosted net earnings, impacting earnings per share positively.
  • 4The company completed the acquisition of Surgical Dynamics' spinal implant business for $135 million on July 1, 2002.
  • 5A plan to close the Rutherford, New Jersey manufacturing facility was announced, with a tentative agreement with the union reached.
  • 6Working capital increased to $540.7 million as of June 30, 2002, indicating healthy operational funding.
  • 7Long-term debt decreased by $105 million during the first six months of 2002, with significant available borrowing capacity remaining.

Frequently Asked Questions

Stryker's sales growth was driven by a combination of increased unit volume and favorable product mix across its Orthopaedic Implants and MedSurg Equipment segments. Higher selling prices and contributions from acquired businesses also played a role, partially offset by foreign currency exchange rate fluctuations.

The adoption of FASB Statement No. 142, which prohibits the amortization of goodwill and certain other intangible assets, reduced amortization expense. This had a positive impact on net earnings, increasing it by $5.3 million ($.03 per diluted share) for the first six months and $2.7 million ($.01 per diluted share) for the second quarter of 2002. The company also tested goodwill for impairment and found no impairment.

Two significant events are highlighted: the acquisition of Surgical Dynamics' spinal implant business, which closed on July 1, 2002, and is expected to impact earnings positively from 2003 onwards. The second is the planned closure of the Rutherford, New Jersey manufacturing facility over the next 18 months, which is expected to enhance gross margins and reduce inventory. A tentative agreement regarding this closure has been reached with the union.

Stryker's long-term debt decreased by $105 million during the first six months of 2002. The company generated strong cash flow from operations ($172.8 million for the six months) and maintained a healthy working capital position ($540.7 million). At June 30, 2002, Stryker had $52.2 million in cash and cash equivalents and $477.3 million of additional borrowing capacity available under its credit facilities, indicating a strong liquidity position.